Co-delivery of doxorubicin and arsenite with reduction and pH dual-sensitive vesicle for synergistic cancer therapy
Author:
Affiliation:
1. PCFM and GDHPPC Labs
2. School of Chemistry and Chemical Engineering
3. Sun Yat-sen University
4. Guangzhou 510275, China
5. Center of Biomedical Engineering
Abstract
A reduction and pH dual-sensitive nanovesicle co-delivers doxorubicin and arsenite for synergistic anticancer therapy.
Funder
National Natural Science Foundation of China
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2016/NR/C5NR07868G
Reference43 articles.
1. Nanoparticle therapeutics: an emerging treatment modality for cancer
2. Stimuli-responsive nanoparticles, nanogels and capsules for integrated multifunctional intelligent systems
3. Antibiofouling Polymer-Coated Superparamagnetic Iron Oxide Nanoparticles as Potential Magnetic Resonance Contrast Agents for in Vivo Cancer Imaging
4. Synthesis of Ultrasensitive Magnetic Resonance Contrast Agents for Cancer Imaging Using PEG-Fatty Acid
5. Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Functionalized polymersomes for cancer therapy;Functionalized Nanomaterials for Cancer Research;2024
2. Stimuli‐Responsive Prodrug Chemistries for Cancer Therapy;ChemBioChem;2023-08-18
3. Intelligent design of polymersomes for antibacterial and anticancer applications;WIREs Nanomedicine and Nanobiotechnology;2022-06-08
4. Lithocholic acid conjugated mPEG-b-PCL micelles for pH responsive delivery to breast cancer cells;International Journal of Pharmaceutics;2022-06
5. Co-delivery of NIR-II semiconducting polymer and pH-sensitive doxorubicin-conjugated prodrug for photothermal/chemotherapy;Acta Biomaterialia;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3